Montelukast Sodium
Catalogue Number: N-3028-1-RPE
| Manufacturer: | rPeptide |
| Physical state: | Powder |
| Type: | Other Inhibitors |
| Shipping Condition: | RT |
| Unit(s): | 50 mg |
Description
Description: Potent, selective CysLT1 receptor (leukotriene D4) antagonist (Ki = 0.18 nM)1,2. Displays anti-inflammatory and anti-asthmatic effects. Clinically useful agent for treatment of chronic asthma3. Attenuates chronic brain injury after focal cerebral ischemia in rodent models4. Decreases blood brain barrier dysfunction in mouse models5. Blockade of GPR17 by montelukast elevates neural stem and progenitor proliferation6.
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations